Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile | MicrobiomeTrials← Back to trialsNCT05389904
Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
CompletedNAINTERVENTIONAL
Trial Details
Start: 2022-07-25Est. Completion: 2025-06-01
Enrollment target: 261 participants Locations- Brigham and Women's Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Recurrent C. Difficile (rCDI)Ulcerative Colitis (UC)Metabolic Syndrome (MetS)
The gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficil…
Rome, ItalyEst. completion Jan 19, 2029
Neutropenia, Febrile
The goal of this clinical trial is to compare a short course of antibiotics in patients in whom no bacterial infection i…
Leuven, BelgiumCompleted Mar 8, 2026
Phase 4
Recruiting
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated InfectionCarbapenem-Resistant Enterobacteriaceae InfectionHospital-acquired Pneumonia
RAPID is an investigator initiated Phase 4, multinational, multicentre, open-label, randomised controlled superiority tr…
Vellore, IndiaEst. completion Oct 31, 2027